Search Results (86)

The increasing demand for safe and high-energy-density battery systems has led to intense research into solid electrolytes for rechargeable batteries. One of these solid electrolytes is the NASICON-type Li_1+xAl_xTi_2−x(PO₄)₃ (LATP) material. In this study, different boron compounds (10% B₂O₃ doped, 10% H₃BO₃ doped, and 5% B₂O₃ + 5% H₃BO₃ doped) were doped at total 10 wt.% into the Ti⁴⁺ sites of an LATP solid electrolyte to investigate the structural properties and ionic conductivity of solid electrolytes using the solid-state synthesis method. Characterization of the synthesized samples was conducted using X-ray diffraction (XRD), Raman spectroscopy, scanning electron microscopy (SEM), and electrochemical impedance spectroscopy (EIS). The XRD patterns of the boron-doped LATP (LABTP) samples show that the samples have a rhombohedral phase with space group R$\overline{3}$c together and low amounts of impurity phases. While all the LABTP samples exhibited similar ionic conductivity values of around 10⁻⁴ S cm⁻¹, the LABTP2 sample doped with 10 wt.% H₃BO₃ demonstrated the highest ionic conductivity. These findings suggest that varying B³⁺ ion doping strategies in LATP can significantly advance the development of solid electrolytes for all-solid-state lithium-ion batteries. Full article

Since solid electrolytes have a broad electrochemical stability window, are exceptionally electrochemically stable against Li metal, and function as a physical separator to prevent dendrite growth, they are at the forefront of alternate possibilities, further increasing the stability and energy density of Li-ion batteries. NASICON-type electrolytes are a promising candidate due to their negligible moisture sensitivity, which results in outstanding stability and a lower probability of Li₂CO₃ passivity under the ambient atmosphere. However, one of the most promising representatives, Li_1+xY_xZr_2−x(PO₄)₃ (LYZP), has multiple stable phases with significant variation in their corresponding Li-ion conductivity. In this paper, we have successfully synthesized the highly ionically conductive rhombohedral phase of LYZP via spray-flame synthesis. Two different solvent mixtures (e.g., 2-ethyl hexanoic acid/ethanol, propanol/propanoic acid) were chosen to explore the effect of precursor composition and combustion enthalpy on the phase composition of the nanoparticle. The as-synthesized nanoparticles from spray-flame synthesis consisted of the crystalline tetragonal zirconia (t-ZrO₂) phase, while lithium, yttrium, and phosphate were present on the nanoparticles’ surface as amorphous phases. However, a short annealing step (1 h) was sufficient to obtain the NASICON phase. Moreover, we have shown the gradual phase conversion from orthorhombic β phase to rhombohedral α phase as the annealing temperature increased from 700 °C to 1300 °C (complete removal of β phase). In this context, Y³⁺ doping was also crucial, along with the appropriate solvent mixture and annealing temperature, for obtaining the much-desired rhombohedral α phase. Further, 0.2 at% Y³+ doping was added to the solvent mixture of 2-ethyl hexanoic acid/ethanol, and annealing at 1300 °C for 1 h resulted in a high ionic conductivity of 1.14∙10⁻⁵ S cm⁻¹. Full article

Purpose: Selinexor is an oral selective inhibitor of exportine-1 (XPO1) with efficacy as a single agent in heavily pretreated diffuse large B-cell lymphoma (DLBCL). We conducted a study investigating the combination of selinexor with rituximab and platinum-based chemotherapy in B-cell lymphoma. Patients and methods: We conducted a phase 1b, dose-escalation, and expansion trial, which enrolled patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Patients received oral selinexor according to a 3 + 3 design in combination with rituximab and dexamethasone, high-dose cytarabine, oxaliplatine (DHAOX) or gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy. Results: A total of 39 patients were enrolled, 27 during the escalation phase and 12 during the expansion phase. Most patients had diffuse large B-cell lymphoma (DLBCL; 77%). Group R-DHAOX was prematurely closed to inclusion due to a recommendation from the French drug agency, independent of this trial. A recommended phase 2 dose (RP2D) of selinexor in association with R-GPD was established at 40 mg on days 1, 8, and 15 of each 21-day cycle. In a population of 18 patients treated at this dose of selinexor, the most frequent grade 3–4 adverse events were hematological. With this regimen, seven obtained a complete metabolic response and five a partial response. The median PFS was 5.8 months. Conclusions: Among the patients with R/R B-cell lymphoma, selinexor at a weekly dose of 40 mg with R-GDP is feasible for outpatients, with a generally acceptable safety profile. Full article

Since the introduction of rituximab in the late 1990s, significant progress has been made in advancing targeted therapies for B cell lymphomas, improving patients’ chance of being cured and clinicians’ therapeutic armamentarium. A better understanding of disease biology and pathogenic pathways, coupled with refinements in immunophenotypic and molecular diagnostics, have been instrumental in these achievements. While traditional chemotherapy remains fundamental in most cases, concerns surrounding chemorefractoriness and cumulative toxicities, particularly the depletion of the hemopoietic reserve, underscore the imperative for personalized treatment approaches. Integrating targeted agents, notably monoclonal antibodies, alongside chemotherapy has yielded heightened response rates and prolonged survival. A notable paradigm shift is underway with innovative-targeted therapies replacing cytotoxic drugs, challenging conventional salvage strategies like stem cell transplantation. This review examines the landscape of emerging targets for lymphoma cells and explores innovative therapies for diffuse large B cell lymphoma (DLBCL). From Chimeric Antigen Receptor-T cells to more potent monoclonal antibodies, antibody–drug conjugates, bispecific antibodies, checkpoint inhibitors, and small molecules targeting intracellular pathways, each modality offers promising avenues for therapeutic advancement. This review aims to furnish insights into their potential implications for the future of DLBCL treatment strategies. Full article

Adjuvant treatment for Glioblastoma Grade 4 with Temozolomide (TMZ) inevitably fails due to therapeutic resistance, necessitating new approaches. Apoptosis induction in GB cells is inefficient, due to an excess of anti-apoptotic XPO1/Bcl-2-family proteins. We assessed TMZ, Methotrexate (MTX), and Cytarabine (Ara-C) (apoptosis inducers) combined with XPO1/Bcl-2/Mcl-1-inhibitors (apoptosis rescue) in GB cell lines and primary GB stem-like cells (GSCs). Using CellTiter-Glo^® and Caspase-3 activity assays, we generated dose–response curves and analyzed the gene and protein regulation of anti-apoptotic proteins via PCR and Western blots. Optimal drug combinations were examined for their impact on the cell cycle and apoptosis induction via FACS analysis, paralleled by the assessment of potential toxicity in healthy mouse brain slices. Ara-C and MTX proved to be 150- to 10,000-fold more potent in inducing apoptosis than TMZ. In response to inhibitors Eltanexor (XPO1; E), Venetoclax (Bcl-2; V), and A1210477 (Mcl-1; A), genes encoding for the corresponding proteins were upregulated in a compensatory manner. TMZ, MTX, and Ara-C combined with E, V, and A evidenced highly lethal effects when combined. As no significant cell death induction in mouse brain slices was observed, we conclude that this drug combination is effective in vitro and expected to have low side effects in vivo. Full article

International terrestrial reference frame (ITRF) input data, generated by Global Navigation Satellite Systems (GNSS), Satellite Laser Ranging (SLR), Very Long Baseline Interferometry (VLBI), and Doppler Orbitography and Radiopositioning integrated by satellite (DORIS) combination centers (CCs), are considered to be relatively high-quality and accurate solutions. Every few years, these input data are submitted to the three ITRS combination centers, namely Institut Géographique National (IGN), Deutsches Geodätisches Forschungsinstitut at the Technische Universität München (DGFI-TUM), and Jet Propulsion Laboratory (JPL), to establish a multi-technique combined terrestrial reference frame (TRF). Generally, these solutions have undergone three rounds of outlier removal: the first at the technique analysis centers during solution generations and the second during the technique-specific combination by the CCs; ITRS CCs then perform a third round of outlier removal and preprocessing during the multi-technique combination of TRFs. However, since the primary objective of CCs is to release the final TRF product, they do not emphasize the publication of analytical preprocessing results, such as the outlier rejection rate. In this paper, our specific focus is on assessing the precision improvement of ITRF input data from 2014 to 2020, which includes evaluating the accuracy of coordinates, the datum accuracy, and the precision of the polar motions, for all four techniques. To achieve the above-mentioned objectives, we independently propose a TRF stacking approach to establish single technical reference frameworks, using software developed by us that is different from the ITRF generation. As a result, roughly 0.5% or less of the SLR observations are identified as outliers, while the ratio of DORIS, GNSS, and VLBI observations are below 1%, around 2%, and ranging from 1% to 1.2%, respectively. It is shown that the consistency between the SLR scale and ITRF has improved, increasing from around −5 mm in ITRF2014 datasets to approximately −1 mm in ITRF2020 datasets. The scale velocity derived from fitting the VLBI scale parameter series with all epochs in ITRF2020 datasets differs by approximately 0.21 mm/year from the velocity obtained by fitting the data up to 2013.75 because of the scale drift of VLBI around 2013. The decreasing standard deviations of the polar motion parameter (XPO, YPO) offsets between Stacking TRFs and 14C04 (20C04) indicate an improvement in the precision of polar motion observations for all four techniques. From the perspective of the weighted root mean square (WRMS) in station coordinates, since the inception of the technique, the station coordinate WRMS of DORIS decreased from 30 mm to 5 mm for X and Y components, and 25 mm to 5 mm for the Z component; SLR WRMS decreased from 20 mm to better than 10 mm (X, Y and Z); GNSS WRMS decreased from 4 mm to 1.5 mm (X and Y) and 5 mm to 2 mm (Z); while VLBI showed no significant change. Full article

Selinexor (Seli) is a first-in-class, oral selective inhibitor of the nuclear export protein, exportin-1 (XPO1). Seli exhibits its antitumor effect through the blockage of XPO1, which increases nuclear retention of tumor suppressor proteins (TSPs), including p53, thereby limiting the translation of oncogenes, triggering cell cycle arrest and the death of malignant cells. Multiple Myeloma (MM) patients with del17p are deficient in TP53 and have a particularly poor prognosis. Given its unique mechanism of action, we investigated whether Seli has increased efficacy in RRMM patients with del17p compared to other high-risk cytogenetics (OHRC). This is an IRB-approved observational study of RRMM patients with high-risk cytogenetics (del17p, t (4;14), t (14;16) or gain 1q) or standard-risk cytogenetics treated at the Levine Cancer Institute (LCI) with a Seli-based regimen between January 2019 and December 2022. Time-to-event endpoints (PFS, OS) were evaluated using Kaplan–Meier (KM) methods. Log-rank tests compared time-to-event endpoints between cohorts [del17p vs. OHRC vs. standard risk]. We identified 40 RRMM patients with high-risk cytogenetics, including 16 patients with del17p and 24 patients with OHRC, as well as 20 with standard-risk cytogenetics. The median age was 62.5 vs. 69 vs. 65.5 years (del17p group vs. OHRC vs. standard risk). The median prior line of therapies was five (range: 3–16) with similar rates of prior autologous stem cell transplant in all arms (68.8% vs. 62.5% vs. 70.0%). The most frequently used regimens were Seli–Pomalidomide–dexamethasone(dex) or Seli–Carfilzomib–dex (Seli-Kd) in the del17p group and Seli-Kd in the OHRC and standard-risk groups. The median time to start the Seli-based regimen after initial MM diagnosis was 5.6 years for the del17p group, 4.1 years in OHRC, and 4.8 years in the standard-risk group. The median follow-up time after the start of the Seli-based regimen was 10.5 months (mos) in the del17p group, 8.4 mos in OHRC, and 10.3 mos in the standard-risk group. In the del17p group, 50% had an objective response, 41.7% in the OHRC, and 35% in the standard-risk group (p = 0.71). Depth of response was also similar across the arms (12.5% vs. 12.5% vs. 10.0% VGPR p = 0.99). The median OS was 10.9 mos in the del17p group, 10.3 mos in the OHRC, and 10.3 mos in the standard-risk group (p = 0.92). The median OS was 15.5 mos for patients who received Seli as a bridging therapy versus 9 mos for Seli use for other reasons rather than as a bridge. Overall, Seli-based regimens showed promising responses even in this heavily pretreated population. Our analysis suggests that Seli-based regimens lead to similar outcomes among RRMM patients with del17p, OHRC, and standard-risk cytogenetics. This contrasts with previously reported outcomes using combinations of novel therapies in this population, where the del17p patients often have a poorer prognosis. Interestingly, our data suggest that Seli is a particularly effective bridging modality for patients preparing for CAR-T cell therapies in our population. Further investigation into this population is warranted, including in earlier lines of therapy, in hopes of seeing a more durable response. Full article

Li-ion cells with a LiMn_xFe_1−xPO₄ (LMFP) and LiNi_{1−x−y−z}Co_xMn_yAl_zO₂ (NCMA) blending cathode show their benefits of lower cost and higher safety compared to barely NCMA cathode-based cells. However, the rate capability of LMFP material is relatively poor compared to NCMA or even LiFePO₄, which is because of the low electronic conductivity of LMFP material and the 1D diffusion channel in its structure. This work discusses the effect on electrochemical performance when blends of various ratios of LMFP are used in an NCMA cathode, with data verified by a 5 Ah pouch cell. This work further investigated the interaction between NCMA and LMFP during charge/discharge. Combining results from experiment and simulation, it evidences that blending more LMFP does not always lead to worse discharge rate but reduces charge rate. Moreover, it is found that, in a constant current discharge/charge process, although the system is under continuous discharge/charge, LMFP works intermittently. This leads to different diffusion polarization states of LMFP in the discharge/charge process and further results in a difference in discharge/charge rate capability. Therefore, to improve rate capability, especially charging rate, using smaller-sized or doped LMFP to improve its diffusion coefficient is an optimized strategy. Full article

Donation after circulatory death (DCD) hearts are predominantly maintained by normothermic blood perfusion (NBP). Nevertheless, it was shown that hypothermic crystalloid perfusion (HCP) is superior to blood perfusion to recondition left ventricular (LV) contractility. However, transcriptomic changes in the myocardium and coronary artery in DCD hearts after HCP and NBP have not been investigated yet. In a pig model, DCD hearts were harvested and maintained for 4 h by NBP (DCD-BP group, N = 8) or HCP with oxygenated histidine–tryptophane–ketoglutarate (HTK) solution (DCD-HTK, N = 8) followed by reperfusion with fresh blood for 2 h. In the DCD group (N = 8), hearts underwent reperfusion immediately after procurement. In the control group (N = 7), no circulatory death was induced. We performed transcriptomics from LV myocardial and left anterior descending (LAD) samples using microarrays (25,470 genes). We applied the Boruta algorithm for variable selection to identify relevant genes. In the DCD-BP group, compared to DCD, six genes were regulated in the myocardium and 1915 genes were regulated in the LAD. In the DCD-HTK group, 259 genes were downregulated in the myocardium and 27 in the LAD; and 52 genes were upregulated in the myocardium and 765 in the LAD, compared to the DCD group. We identified seven genes of relevance for group identification: ITPRIP, G3BP1, ARRDC3, XPO6, NOP2, SPTSSA, and IL-6. NBP resulted in the upregulation of genes involved in mitochondrial calcium accumulation and ROS production, the reduction in microvascular endothelial sprouting, and inflammation. HCP resulted in the downregulation of genes involved in NF-κB-, STAT3-, and SASP-activation and inflammation. Full article

Renewable electricity products, for example, from wind and photovoltaic energy, need large-scale and economic energy storage systems to guarantee the requirements of our daily lives. Sodium-ion batteries are considered more economical than lithium-ion batteries in this area. Na₃V₂(PO₄)₂F₃, NaVPO₄F, and Na₃(VO)₂(PO₄)₂F are one type of material that may be used for Na-ion batteries. In order to better understand the synthesis of these materials, the phase formation in a NaH₂PO₄–VOSO₄–NaF–H₂O system under hydrothermal conditions was studied and is reported herein. This research focused on the influences of the sodium fluoride content and hydrothermal crystallization time on phase formation and phase purity. The phase transformation between Na(VO)₂(PO₄)₂(H₂O)₄ and Na₃V₂O_2x(PO₄)₂F_3-2x was also studied. Na₃V₂O_2x(PO₄)₂F_3-2x with a high degree of crystallinity can be obtained in as short as 2 h via hydrothermal synthesis using a conventional oven at 170 °C without agitation. All compounds obtained in this research were studied mainly using powder X-ray diffraction, scanning electron microscopy, energy-dispersive X-ray spectrometry, and Fourier-transform infrared spectroscopy. Full article

In eukaryotic cells, the spatial distribution between cytoplasm and nucleus is essential for cell homeostasis. This dynamic distribution is selectively regulated by the nuclear pore complex (NPC), which allows the passive or energy-dependent transport of proteins between these two compartments. Viruses possess many strategies to hijack nucleocytoplasmic shuttling for the benefit of their viral replication. Here, we review how viruses interfere with the karyopherin CRM1 that controls the nuclear export of protein cargoes. We analyze the fact that the viral hijacking of CRM1 provokes are-localization of numerous cellular factors in a suitable place for specific steps of viral replication. While CRM1 emerges as a critical partner for viruses, it also takes part in antiviral and inflammatory response regulation. This review also addresses how CRM1 hijacking affects it and the benefits of CRM1 inhibitors as antiviral treatments. Full article

Solid-state batteries (SSBs) with Li-ion conductive electrolytes made from polymers, thiophosphates (sulfides) or oxides instead of liquid electrolytes have different challenges in material development and manufacturing. For oxide-based SSBs, the co-sintering of a composite cathode is one of the main challenges. High process temperatures cause undesired decomposition reactions of the active material and the solid electrolyte. The formed phases inhibit the high energy and power density of ceramic SSBs. Therefore, the selection of suitable material combinations as well as the reduction of the sintering temperatures are crucial milestones in the development of ceramic SSBs. In this work, the co-sintering behavior of Li_1.3Al_0.3Ti_1.7(PO₄)₃ (LATP) as a solid electrolyte with Li-ion conductivity of ≥0.38 mS/cm and LiFePO₄ with a C-coating (LFP) as a Li-ion storage material (active material) is investigated. The shrinkage behavior, crystallographic analysis and microstructural changes during co-sintering at temperatures between 650 and 850 °C are characterized in a simplified model system by mixing, pressing and sintering the LATP and LFP and compared with tape-casted composite cathodes (d = 55 µm). The tape-casted and sintered composite cathodes were infiltrated by liquid electrolyte as well as polyethylene oxide (PEO) electrolyte and electrochemically characterized as half cells against a Li metal anode. The results indicate the formation of reaction layers between LATP and LFP during co-sintering. At T_s > 750 °C, the rhombohedral LATP phase is transformed into an orthorhombic Li_1.3+xAl_0.3−yFe_x+yTi_1.7−x(PO₄)₃ (LAFTP) phase. During co-sintering, Fe³⁺ diffuses into the LATP phase and partially occupies the Al³⁺ and Ti⁴⁺ sites of the NASICON structure. The formation of this LAFTP leads to significant changes in the electrochemical properties of the infiltrated composite tapes. Nevertheless, a high specific capacity of 134 mAh g⁻¹ is measured by infiltrating the sintered composite tapes with liquid electrolytes. Additionally, infiltration with a PEO electrolyte leads to a capacity of 125 mAh g⁻¹. Therefore, the material combination of LATP and LFP is a promising approach to realize sintered ceramic SSBs. Full article

Since the description of primary mediastinal large B-cell lymphoma (PMBL) as a distinct entity from diffuse large B-cell lymphomas (DLBCL), numerous studies have made it possible to improve their definition. Despite this, this differential diagnosis can be challenging in daily practice. However, in some centers, PMBL may be treated according to a particular regimen, distinct from those used in DLBCL, emphasizing the importance of accurate identification at diagnosis. This study aimed to describe the histological and molecular characteristics of PMBL to improve the accuracy of their diagnosis. Forty-nine cases of PMBL were retrospectively retrieved. The mean age at diagnosis was 39 years (21–83), with a sex ratio of 0.88. All cases presented a fibrous background with diffuse growth of intermediate to large cells with an eosinophil (26/49, 53%) or retracted cytoplasm (23/49, 47%). “Hodgkin-like” cells were observed in 65% of cases (32/49, 65%). The phenotype was: BCL6+ (47/49, 96%), MUM1+ (40/49, 82%), CD30+ (43/49, 88%), and CD23+ (37/49, 75%). Genomic DNAs were tested by next generation sequencing of 33 cases using a custom design panel. Pathogenic variants were found in all cases. The most frequent mutations were: SOCS1 (30/33, 91%), TNFAIP3 (18/33, 54.5%), ITPKB (17/33, 51.5%), GNA13 (16/33, 48.5%), CD58 (12/33, 36.4%), B2M (12/33; 36.4%), STAT6 (11/33, 33.3%) as well as ARID1A (10/33, 30.3%), XPO1 (9/33, 27.3%), CIITA (8/33, 24%), and NFKBIE (8/33, 24%). The present study describes a PMBL cohort on morphological, immunohistochemical, and molecular levels to provide pathologists with daily routine tools. These data also reinforce interest in an integrated histomolecular diagnosis to allow a precision diagnosis as early as possible. Full article

The global trend of rising (male) infertility is concerning, and the unidentifiable causes in half of the cases, the so-called unknown origin male infertility (UOMI), demands a better understanding and assessment of both external/internal factors and mechanisms potentially involved. In this work, it was our aim to obtain new insight on UOMI, specifically on idiopathic (ID) and Unexplained male infertility (UMI), relying on a detailed evaluation of the male gamete, including functional, metabolic and proteomic aspects. For this purpose, 1114 semen samples, from males in couples seeking infertility treatment, were collected at the Reproductive Medicine Unit from the Centro Hospitalar e Universitário de Coimbra (CHUC), from July 2018–July 2022. Based on the couples’ clinical data, seminal/hormonal analysis, and strict eligibility criteria, samples were categorized in 3 groups, control (CTRL), ID and UMI. Lifestyle factors and anxiety/depression symptoms were assessed via survey. Sperm samples were evaluated functionally, mitochondrially and using proteomics. The results of Assisted Reproduction Techniques were assessed whenever available. According to our results, ID patients presented the worst sperm functional profile, while UMI patients were similar to controls. The proteomic analysis revealed 145 differentially expressed proteins, 8 of which were specifically altered in ID and UMI samples. Acrosin (ACRO) and sperm acrosome membrane-associated protein 4 (SACA4) were downregulated in ID patients while laminin subunit beta-2 (LAMB2), mannose 6-phosphate isomerase (MPI), ATP-dependent 6-phosphofructokinase liver type (PFKAL), STAR domain-containing protein 10 (STA10), serotransferrin (TRFE) and exportin-2 (XPO2) were downregulated in UMI patients. Using random forest analysis, SACA4 and LAMB2 were identified as the sperm proteins with a higher chance of distinguishing ID and UMI patients, and their function and expression variation were in accordance with the functional results. No alterations were observed in terms of lifestyle and psychological factors among the 3 groups. These findings obtained in an experimental setting based on 3 well-defined groups of subjects, might help to validate new biomarkers for unknown origin male infertility (ID and UMI) that, in the future, can be used to improve diagnostics and treatments. Full article

To determine the intracellular behavior of p62, a marker of selective autophagy, in oral potentially malignant disorders (OPMDs). This retrospective study includes 70 patients who underwent biopsy or surgical resection and were definitively diagnosed with OPMDs. Immunohistochemical staining for p62, XPO1, p53, and ki67 was performed on all samples and positive cell occupancy was calculated. We statistically investigated the correlation between protein expression in OPMDs and the association between malignant transformation, clinicopathological characteristics, and occupancy. ki67 expression was negatively correlated with p62 expression in the nucleus (p < 0.01) and positively correlated with p62 expression in the cytoplasm (p < 0.01). For malignant transformation, the expression of p62 in the nucleus (p = 0.03) was significantly lower in malignant transformation cases, whereas the expression of p62 in the cytoplasm (p = 0.03) and the aggregation expression (p < 0.01) were significantly higher. Our results suggest that the function of p62 is altered by its subcellular localization. In addition, defects in selective autophagy occur in cases of malignant transformation, suggesting that p62 is a potential biomarker of the risk of malignant transformation of OPMDs. Full article